Clinical relevance of circulating tumor DNA in HER2-positive advanced gastric cancer: a collaborative study of a phase Ib trial of dual HER2 and PD-1 targeted therapy (Ni-High)
Clinical relevance of circulating tumor DNA in HER2-positive advanced gastric cancer: a collaborative study of a phase Ib trial of dual HER2 and PD-1 targeted therapy (Ni-High)
Hirokazu Shoji, Akira Ooki, Shigehisa Kitano, Naoki Ishizuka et al.
Citations
3 citations
Journal
Therapeutic Advances in Medical Oncology
Topics
Gastric Cancer Management and Outcomes
Field-Weighted Citation Impact (FWCI)
4.56
article
Clinical relevance of circulating tumor DNA in HER2-positive advanced gastric cancer: a collaborative study of a phase Ib trial of dual HER2 and PD-1 targeted therapy (Ni-High)
Tokyo University of Science (JP), Gunma University (JP), Kyoto University (JP), Chiba Cancer Center (JP), Saitama Cancer Center (JP), The Cancer Institute Hospital (JP), National Cancer Center Hospital East (JP), Japanese Foundation For Cancer Research (JP)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Clinical relevance of circulating tumor DNA in HER2-positive advanced gastric cancer: a collaborative study of a phase Ib trial of dual HER2 and PD-1 targeted therapy (Ni-High) — Hirokazu Shoji, Akira Ooki, et al. · Therapeutic Advances in Medical Oncology (2025) | TGRS Research Map | TGRS